Low dose ColchicinE in pAtients with peripheral Artery DiseasE to address residual vascular Risk (LEADER-PAD): A randomized trial (Vanguard Phase) Grant uri icon

  •  
  • Overview
  •  
  • Affiliation
  •  
  • View All
  •  

date/time interval

  • April 1, 2021 - September 30, 2023

total award amount

  • CAD 336600